This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2004 Mar;28(3):218-20.

doi: 10.1016/s0399-8320(04)94886-5.

[Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants]

[Article in French]

Laurent Beaugerie¹

Affiliations

Affiliation

¹ Service de Gastroentérologie et Nutrition, Fédération d'Hépato-Gastro-Entérologie, Hôpital Saint-Antoine, 75571 Paris Cedex 12. laurent.beaugerie@sat.ap-hop-paris.fr

PMID: 15094669
DOI: 10.1016/s0399-8320(04)94886-5

Free article

[Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants]

[Article in French]

Laurent Beaugerie. Gastroenterol Clin Biol. 2004 Mar.

Free article

. 2004 Mar;28(3):218-20.

doi: 10.1016/s0399-8320(04)94886-5.

Author

Laurent Beaugerie¹

Affiliation

¹ Service de Gastroentérologie et Nutrition, Fédération d'Hépato-Gastro-Entérologie, Hôpital Saint-Antoine, 75571 Paris Cedex 12. laurent.beaugerie@sat.ap-hop-paris.fr

PMID: 15094669
DOI: 10.1016/s0399-8320(04)94886-5

No abstract available

PubMed Disclaimer

Similar articles

Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.
Bewtra M, Lewis JD. Bewtra M, et al. Expert Rev Clin Immunol. 2010 Jul;6(4):621-31. doi: 10.1586/eci.10.36. Expert Rev Clin Immunol. 2010. PMID: 20594135 Free PMC article. Review.
Risk of lymphoma: inflammatory bowel disease and immunomodulators.
Ang YS, Farrell RJ. Ang YS, et al. Gut. 2006 Apr;55(4):580-1. Gut. 2006. PMID: 16531538 Free PMC article. No abstract available.
Immunosuppression, IBD, and risk of lymphoma.
Bebb JR, Aithal GP, Logan RP. Bebb JR, et al. Gut. 2002 Aug;51(2):296. doi: 10.1136/gut.51.2.296. Gut. 2002. PMID: 12117900 Free PMC article. No abstract available.
Lymphoma in inflammatory bowel disease and treatment decisions.
Bewtra M. Bewtra M. Am J Gastroenterol. 2012 Jul;107(7):964-70. doi: 10.1038/ajg.2011.479. Am J Gastroenterol. 2012. PMID: 22764018 Review.
Azathioprine and mercaptopurine: lymphoma.
[No authors listed] [No authors listed] Prescrire Int. 2011 May;20(116):126. Prescrire Int. 2011. PMID: 21648178

See all similar articles

Cited by

Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.
Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN. Desai A, et al. Inflamm Bowel Dis. 2013 Feb;19(2):309-15. doi: 10.1002/ibd.23026. Inflamm Bowel Dis. 2013. PMID: 22605668 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Masson (France)
Medical
- MedlinePlus Health Information